Summary of patient characteristics and CKD testing
| . | All . | Hypertension . | Diabetes . | Both . |
|---|---|---|---|---|
| N | 28,277,893 | 18,030,710 | 4,567,453 | 5,679,730 |
| Age (mean ± SD) at index of patient history* | 60.6 ± 14.8 | 60.7 ± 15.2 | 58.2 ± 15.1 | 62.3 ± 12.9 |
| Female (%) | 53.6 | 54.2 | 52.9 | 52.2 |
| Percentage of patients who had eGFR ordered at least once | 89.6 | 90.0 | 83.6 | 93.3 |
| eGFR (mL/min/1.73 m2), median (IQR) at index of patient history* | 89.0 (32.0) | 89.0 (31.0) | 95.0 (33.0) | 88.0 (34.0) |
| Percentage of patients who had uACR/uPCR ordered at least once | 21.0 | 11.3 | 32.2 | 43.0 |
| uACR (mg/g), median (IQR) at index of patient history* | 11.9 (32.4) | 9.6 (23.0) | 11.9 (31.5) | 14.1 (40.9) |
| Percentage of patients completely assessed (both tests) at least once | 19.7 | 10.5 | 28.7 | 41.4 |
| Cases per 6 patient-years | 1.15 | 0.58 | 1.69 | 1.98 |
| . | All . | Hypertension . | Diabetes . | Both . |
|---|---|---|---|---|
| N | 28,277,893 | 18,030,710 | 4,567,453 | 5,679,730 |
| Age (mean ± SD) at index of patient history* | 60.6 ± 14.8 | 60.7 ± 15.2 | 58.2 ± 15.1 | 62.3 ± 12.9 |
| Female (%) | 53.6 | 54.2 | 52.9 | 52.2 |
| Percentage of patients who had eGFR ordered at least once | 89.6 | 90.0 | 83.6 | 93.3 |
| eGFR (mL/min/1.73 m2), median (IQR) at index of patient history* | 89.0 (32.0) | 89.0 (31.0) | 95.0 (33.0) | 88.0 (34.0) |
| Percentage of patients who had uACR/uPCR ordered at least once | 21.0 | 11.3 | 32.2 | 43.0 |
| uACR (mg/g), median (IQR) at index of patient history* | 11.9 (32.4) | 9.6 (23.0) | 11.9 (31.5) | 14.1 (40.9) |
| Percentage of patients completely assessed (both tests) at least once | 19.7 | 10.5 | 28.7 | 41.4 |
| Cases per 6 patient-years | 1.15 | 0.58 | 1.69 | 1.98 |
Patient demographics and guideline-recommended CKD testing rates in at-risk individuals with hypertension, diabetes, or both between 2013 and 2018.
Index represents the first time a patient appears during the study time frame.